Filtered By:
Drug: Methylprednisolone
This page shows you your search results in order of date.
Order by Relevance | Date
Total 691 results found since Jan 2013.
Case Report: Spectrum of interesting ocular manifestations following COVID-19 vaccination: a case series of real-world presentations
Conclusions and importanceVisual symptoms and various ocular adverse events can occur following COVID-19 vaccination, which warrants further investigation and urgent intervention if necessary. We would suggest patients receiving the COVID-19 vaccination be aware of possible ocular complications and report any symptoms, regardless of severity.
Source: Frontiers in cellular and infection microbiology - September 15, 2023 Category: Microbiology Source Type: research
Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
Previous studies have shown mortality benefits with corticosteroids in Coronavirus disease-19 (COVID-19). However, there is inconsistency regarding the use of methylprednisolone over dexamethasone in COVID-19,...
Source: BMC Pulmonary Medicine - August 28, 2023 Category: Respiratory Medicine Authors: Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali Altebainawi, Reham Alharbi, Maha Assadoon, Ramesh Vishwakarma, Nadia H. Ismail, Asma A. Alshehri, Faisal E. Al Mutairi, Mashael AlFaifi, Abdullah F. Alharthi, Abeer A. Alenazi, Mai Alalawi, Omar A Tags: Research Source Type: research
Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review
Intern Med. 2023;62(16):2419-2425. doi: 10.2169/internalmedicine.1365-22. Epub 2023 Aug 15.ABSTRACTWe herein report a rare case of distal chronic inflammatory demyelinating polyneuropathy (CIDP) following coronavirus disease 2019 (COVID-19) vaccination. A 39-year-old woman with a solitary plasmacytoma developed general weakness 7 days after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, which had progressed for 3 months. A neurological examination revealed limb weakness with areflexia. Serological tests identified the presence of IgG antibodies against anti-GM1 and anti-GM2 gangliosides. Comprehensive e...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Takafumi Kubota Tomomi Shijo Kensho Ikeda Yoshihiko Mitobe Shu Umezawa Tatsuro Misu Takafumi Hasegawa Masashi Aoki Source Type: research
Acute Interstitial Nephritis with Glomerular Capillary IgA Deposition Following SARS-CoV-2 mRNA Vaccination
Intern Med. 2023;62(16):2381-2387. doi: 10.2169/internalmedicine.1631-23. Epub 2023 Aug 15.ABSTRACTWe herein report a case of acute kidney injury (AKI) presenting as acute interstitial nephritis (AIN) after the first dose of the BNT162b2 mRNA vaccine against coronavirus disease 2019 (COVID-19). A 69-year-old man with a history of diabetes and hypertension presented with AKI 4 days after receiving the vaccine. Despite the administration of methylprednisolone pulse treatment, his renal function worsened, which prompted us to initiate temporal hemodialysis. His renal function subsequently improved, and a renal biopsy confirme...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Erika Hishida Yuko Ono Kazuho Oe Toshimi Imai Hiromichi Yoshizawa Takeo Nakaya Hirotoshi Kawata Tetsu Akimoto Osamu Saito Daisuke Nagata Source Type: research
Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review
Intern Med. 2023;62(16):2419-2425. doi: 10.2169/internalmedicine.1365-22. Epub 2023 Aug 15.ABSTRACTWe herein report a rare case of distal chronic inflammatory demyelinating polyneuropathy (CIDP) following coronavirus disease 2019 (COVID-19) vaccination. A 39-year-old woman with a solitary plasmacytoma developed general weakness 7 days after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, which had progressed for 3 months. A neurological examination revealed limb weakness with areflexia. Serological tests identified the presence of IgG antibodies against anti-GM1 and anti-GM2 gangliosides. Comprehensive e...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Takafumi Kubota Tomomi Shijo Kensho Ikeda Yoshihiko Mitobe Shu Umezawa Tatsuro Misu Takafumi Hasegawa Masashi Aoki Source Type: research
Acute Interstitial Nephritis with Glomerular Capillary IgA Deposition Following SARS-CoV-2 mRNA Vaccination
Intern Med. 2023;62(16):2381-2387. doi: 10.2169/internalmedicine.1631-23. Epub 2023 Aug 15.ABSTRACTWe herein report a case of acute kidney injury (AKI) presenting as acute interstitial nephritis (AIN) after the first dose of the BNT162b2 mRNA vaccine against coronavirus disease 2019 (COVID-19). A 69-year-old man with a history of diabetes and hypertension presented with AKI 4 days after receiving the vaccine. Despite the administration of methylprednisolone pulse treatment, his renal function worsened, which prompted us to initiate temporal hemodialysis. His renal function subsequently improved, and a renal biopsy confirme...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Erika Hishida Yuko Ono Kazuho Oe Toshimi Imai Hiromichi Yoshizawa Takeo Nakaya Hirotoshi Kawata Tetsu Akimoto Osamu Saito Daisuke Nagata Source Type: research
Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review
Intern Med. 2023;62(16):2419-2425. doi: 10.2169/internalmedicine.1365-22. Epub 2023 Aug 15.ABSTRACTWe herein report a rare case of distal chronic inflammatory demyelinating polyneuropathy (CIDP) following coronavirus disease 2019 (COVID-19) vaccination. A 39-year-old woman with a solitary plasmacytoma developed general weakness 7 days after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, which had progressed for 3 months. A neurological examination revealed limb weakness with areflexia. Serological tests identified the presence of IgG antibodies against anti-GM1 and anti-GM2 gangliosides. Comprehensive e...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Takafumi Kubota Tomomi Shijo Kensho Ikeda Yoshihiko Mitobe Shu Umezawa Tatsuro Misu Takafumi Hasegawa Masashi Aoki Source Type: research
Acute Interstitial Nephritis with Glomerular Capillary IgA Deposition Following SARS-CoV-2 mRNA Vaccination
Intern Med. 2023;62(16):2381-2387. doi: 10.2169/internalmedicine.1631-23. Epub 2023 Aug 15.ABSTRACTWe herein report a case of acute kidney injury (AKI) presenting as acute interstitial nephritis (AIN) after the first dose of the BNT162b2 mRNA vaccine against coronavirus disease 2019 (COVID-19). A 69-year-old man with a history of diabetes and hypertension presented with AKI 4 days after receiving the vaccine. Despite the administration of methylprednisolone pulse treatment, his renal function worsened, which prompted us to initiate temporal hemodialysis. His renal function subsequently improved, and a renal biopsy confirme...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Erika Hishida Yuko Ono Kazuho Oe Toshimi Imai Hiromichi Yoshizawa Takeo Nakaya Hirotoshi Kawata Tetsu Akimoto Osamu Saito Daisuke Nagata Source Type: research
Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review
Intern Med. 2023;62(16):2419-2425. doi: 10.2169/internalmedicine.1365-22. Epub 2023 Aug 15.ABSTRACTWe herein report a rare case of distal chronic inflammatory demyelinating polyneuropathy (CIDP) following coronavirus disease 2019 (COVID-19) vaccination. A 39-year-old woman with a solitary plasmacytoma developed general weakness 7 days after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, which had progressed for 3 months. A neurological examination revealed limb weakness with areflexia. Serological tests identified the presence of IgG antibodies against anti-GM1 and anti-GM2 gangliosides. Comprehensive e...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Takafumi Kubota Tomomi Shijo Kensho Ikeda Yoshihiko Mitobe Shu Umezawa Tatsuro Misu Takafumi Hasegawa Masashi Aoki Source Type: research
Acute Interstitial Nephritis with Glomerular Capillary IgA Deposition Following SARS-CoV-2 mRNA Vaccination
Intern Med. 2023;62(16):2381-2387. doi: 10.2169/internalmedicine.1631-23. Epub 2023 Aug 15.ABSTRACTWe herein report a case of acute kidney injury (AKI) presenting as acute interstitial nephritis (AIN) after the first dose of the BNT162b2 mRNA vaccine against coronavirus disease 2019 (COVID-19). A 69-year-old man with a history of diabetes and hypertension presented with AKI 4 days after receiving the vaccine. Despite the administration of methylprednisolone pulse treatment, his renal function worsened, which prompted us to initiate temporal hemodialysis. His renal function subsequently improved, and a renal biopsy confirme...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Erika Hishida Yuko Ono Kazuho Oe Toshimi Imai Hiromichi Yoshizawa Takeo Nakaya Hirotoshi Kawata Tetsu Akimoto Osamu Saito Daisuke Nagata Source Type: research
Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review
Intern Med. 2023;62(16):2419-2425. doi: 10.2169/internalmedicine.1365-22. Epub 2023 Aug 15.ABSTRACTWe herein report a rare case of distal chronic inflammatory demyelinating polyneuropathy (CIDP) following coronavirus disease 2019 (COVID-19) vaccination. A 39-year-old woman with a solitary plasmacytoma developed general weakness 7 days after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, which had progressed for 3 months. A neurological examination revealed limb weakness with areflexia. Serological tests identified the presence of IgG antibodies against anti-GM1 and anti-GM2 gangliosides. Comprehensive e...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Takafumi Kubota Tomomi Shijo Kensho Ikeda Yoshihiko Mitobe Shu Umezawa Tatsuro Misu Takafumi Hasegawa Masashi Aoki Source Type: research
Acute Interstitial Nephritis with Glomerular Capillary IgA Deposition Following SARS-CoV-2 mRNA Vaccination
Intern Med. 2023;62(16):2381-2387. doi: 10.2169/internalmedicine.1631-23. Epub 2023 Aug 15.ABSTRACTWe herein report a case of acute kidney injury (AKI) presenting as acute interstitial nephritis (AIN) after the first dose of the BNT162b2 mRNA vaccine against coronavirus disease 2019 (COVID-19). A 69-year-old man with a history of diabetes and hypertension presented with AKI 4 days after receiving the vaccine. Despite the administration of methylprednisolone pulse treatment, his renal function worsened, which prompted us to initiate temporal hemodialysis. His renal function subsequently improved, and a renal biopsy confirme...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Erika Hishida Yuko Ono Kazuho Oe Toshimi Imai Hiromichi Yoshizawa Takeo Nakaya Hirotoshi Kawata Tetsu Akimoto Osamu Saito Daisuke Nagata Source Type: research
Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review
Intern Med. 2023;62(16):2419-2425. doi: 10.2169/internalmedicine.1365-22. Epub 2023 Aug 15.ABSTRACTWe herein report a rare case of distal chronic inflammatory demyelinating polyneuropathy (CIDP) following coronavirus disease 2019 (COVID-19) vaccination. A 39-year-old woman with a solitary plasmacytoma developed general weakness 7 days after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, which had progressed for 3 months. A neurological examination revealed limb weakness with areflexia. Serological tests identified the presence of IgG antibodies against anti-GM1 and anti-GM2 gangliosides. Comprehensive e...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Takafumi Kubota Tomomi Shijo Kensho Ikeda Yoshihiko Mitobe Shu Umezawa Tatsuro Misu Takafumi Hasegawa Masashi Aoki Source Type: research
Acute Interstitial Nephritis with Glomerular Capillary IgA Deposition Following SARS-CoV-2 mRNA Vaccination
Intern Med. 2023;62(16):2381-2387. doi: 10.2169/internalmedicine.1631-23. Epub 2023 Aug 15.ABSTRACTWe herein report a case of acute kidney injury (AKI) presenting as acute interstitial nephritis (AIN) after the first dose of the BNT162b2 mRNA vaccine against coronavirus disease 2019 (COVID-19). A 69-year-old man with a history of diabetes and hypertension presented with AKI 4 days after receiving the vaccine. Despite the administration of methylprednisolone pulse treatment, his renal function worsened, which prompted us to initiate temporal hemodialysis. His renal function subsequently improved, and a renal biopsy confirme...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Erika Hishida Yuko Ono Kazuho Oe Toshimi Imai Hiromichi Yoshizawa Takeo Nakaya Hirotoshi Kawata Tetsu Akimoto Osamu Saito Daisuke Nagata Source Type: research
Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone
ConclusionThese findings suggest MP treatment could ameliorate levels of myoglobin and FABP3, but appeared to have no impact on HMGB1, TnI and NTproBNP. In addition, methylprednisolone relieves the COVID-19 induced inflammatory response by diminishing MIG and IP-10 levels. Overall, corticosteroid (methylprednisolone) use in COVID-19 management influences the immunological molecule and injury biomarker profile in COVID-19 patients.
Source: Frontiers in Immunology - August 16, 2023 Category: Allergy & Immunology Source Type: research
